Scorpius Holdings, Inc.

NYSEAM:SCPX Stock Report

Market Cap: US$6.9m

Scorpius Holdings Balance Sheet Health

Financial Health criteria checks 4/6

Scorpius Holdings has a total shareholder equity of $28.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $51.0M and $22.7M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$2.39m
EquityUS$28.29m
Total liabilitiesUS$22.74m
Total assetsUS$51.04m

Recent financial health updates

Here's Why We're Watching Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation

Dec 28
Here's Why We're Watching Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation

Recent updates

Here's Why We're Watching Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation

Dec 28
Here's Why We're Watching Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation

Here's Why We're Not Too Worried About Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation

Sep 02
Here's Why We're Not Too Worried About Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation

Heat Biologics names Anthony Manning as chief scientific advisor

May 10

Heat Biologics EPS misses by $0.01, misses on revenue

May 05

We're Hopeful That Heat Biologics (NASDAQ:HTBX) Will Use Its Cash Wisely

Apr 30
We're Hopeful That Heat Biologics (NASDAQ:HTBX) Will Use Its Cash Wisely

Reflecting on Heat Biologics' (NASDAQ:HTBX) Share Price Returns Over The Last Five Years

Mar 07
Reflecting on Heat Biologics' (NASDAQ:HTBX) Share Price Returns Over The Last Five Years

Here's Why We're Not Too Worried About Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation

Jan 13
Here's Why We're Not Too Worried About Heat Biologics' (NASDAQ:HTBX) Cash Burn Situation

Heat Biologics signs a licensing agreement; Appoints new CFO

Jan 06

Heat Biologics soars 14% on completion of ZVX-60 vaccine cell line for COVID-19

Dec 16

Introducing Heat Biologics (NASDAQ:HTBX), The Stock That Zoomed 124% In The Last Year

Nov 20
Introducing Heat Biologics (NASDAQ:HTBX), The Stock That Zoomed 124% In The Last Year

Heat Biologics Provides Update, And Other News: The Good, Bad And Ugly Of Biopharma

Nov 02

Financial Position Analysis

Short Term Liabilities: SCPX's short term assets ($4.8M) do not cover its short term liabilities ($10.1M).

Long Term Liabilities: SCPX's short term assets ($4.8M) do not cover its long term liabilities ($12.6M).


Debt to Equity History and Analysis

Debt Level: SCPX is debt free.

Reducing Debt: SCPX had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SCPX has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: SCPX is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.